Abstract
Second-generation drug-eluting stents (DES) have demonstrated superiority over first-generation DES with respect to reduction in MACE and target lesion revascularization (TLR). The aim of this study was to compare the clinical presentation, lesion characteristics, and outcomes of first-generation
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
